Skip to Content

Soo Romanoff

Soo Romanoff is an equity analyst for Morningstar.

More From Soo Romanoff

Stabilizing pricing and improved efficiencies should lead to steady gains and needed debt repayments for the generic drugmakers.

More About Soo Romanoff

Soo Romanoff is an equity analyst for Morningstar Research Services LLC, a wholly owned subsidiary of Morningstar, Inc. She covers pharmaceutical distributors, pharmacies, generic pharmaceutical manufacturers, and healthcare IT companies.

Before joining Morningstar in 2019, Romanoff spent nearly 20 years in healthcare mergers and acquisitions at Houlihan Lokey and Huron Consulting and five years in equity research at UBS Warburg covering telecom and Internet companies.

Romanoff holds a bachelor’s degree from the University of Pennsylvania.

Sponsor Center